{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:32:48Z","timestamp":1740162768880,"version":"3.37.3"},"reference-count":31,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,10,16]]},"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Stroke is a leading cause of death and disability. The development of dementia after stroke is common. Vascular risk factors (VRF) which contribute to stroke risk can also contribute to cognitive decline, especially in vascular dementia (VaD). There is no established treatment for VaD, therefore strategies for prevention could have major health resource implications. This study was designed to assess whether patients with early cognitive decline after stroke\/transient ischaemic attack (TIA) can be easily identified and whether target-driven VRF management can prevent progression to dementia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The primary objective is to establish the feasibility of recruitment and retention of patients with early cognitive decline to a randomised controlled trial of enhanced VRF management. Secondary objectives include: (a) to determine the potential clinical benefit of the intervention; (b) to estimate the sample size for a future definitive multicentre randomised controlled trial; (c) to inform a future economic evaluation; (d) to explore the link between VRF control and the incidence of cognitive impairment on longitudinal follow-up in a UK population after stroke\/TIA with current routine management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>100 patients with cognitive decline poststroke\/TIA will be recruited from stroke services at the Norfolk and Norwich University Hospital. After collection of baseline data, they will be randomised to intervention (3 monthly follow-up with enhanced management) or control (treatment as usual by the general practitioner). At 12 months outcomes (repeat cognitive testing, VRF assessment) will be assessed. A further 100 patients without cognitive decline will be recruited to a parallel observational group from the same site. At 12 months they will have repeat cognitive testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Ethical approval has been granted in England. Dissemination is planned via publication in peer-reviewed medical journals and presentation at relevant conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>42688361; Pre-results.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2017-017416","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T21:32:50Z","timestamp":1715895170000},"page":"e017416","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory)"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3852-6158","authenticated-orcid":false,"given":"Phyo Kyaw","family":"Myint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon K","family":"Loke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Mattishent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Christopher","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Fleetcroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Shepstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"2024051614324389000_7.11.e017416.1","unstructured":"The Stroke Association. State of the Nation: stroke statistics. 2017. https:\/\/www.stroke.org.uk\/resources\/state-nation-stroke-statistics (accessed 17 Jul 2017)."},{"key":"2024051614324389000_7.11.e017416.2","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0b013e32830fe465"},{"key":"2024051614324389000_7.11.e017416.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820f2e38"},{"key":"2024051614324389000_7.11.e017416.4","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afr079"},{"key":"2024051614324389000_7.11.e017416.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.7.1494"},{"key":"2024051614324389000_7.11.e017416.6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12626"},{"key":"2024051614324389000_7.11.e017416.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70221-0"},{"key":"2024051614324389000_7.11.e017416.8","unstructured":"Wimo A , Prince M . World Alzheimer Report 2010: the global economic impact of Dementia, 2010. https:\/\/www.alz.co.uk\/research\/world-report-2010 (accessed 21 Aug 2017)."},{"key":"2024051614324389000_7.11.e017416.9","unstructured":"National Audit Office. Reducing Brain Damage: faster access to better stroke care, 2005. https:\/\/www.nao.org.uk\/report\/department-of-health-reducing-brain-damage-faster-access-to-better-stroke-care\/ (accessed 17 Jul 2017)."},{"key":"2024051614324389000_7.11.e017416.10","unstructured":"Luengo-Fernandez R , Leal J , Gray A . Dementia 2010 - the prevalence, economic cost and research funding of dementia compared with other major diseases. Great Shelford: Alzheimer\u2019s Research Trust, 2010. https:\/\/www.cddft.nhs.uk\/media\/185806\/dementia%202010%20exec%20summary.pdf (accessed 21 Aug 2017)."},{"key":"2024051614324389000_7.11.e017416.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70029-7"},{"key":"2024051614324389000_7.11.e017416.12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr273"},{"key":"2024051614324389000_7.11.e017416.13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.005205"},{"key":"2024051614324389000_7.11.e017416.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70236-4"},{"key":"2024051614324389000_7.11.e017416.15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.archger.2011.04.025","article-title":"Role of cardiovascular risk factors (CRF) in the patients with mild cognitive impairment (MCI)","volume":"54","author":"Ettorre","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"2024051614324389000_7.11.e017416.16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.651778"},{"key":"2024051614324389000_7.11.e017416.17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/VHRM.S1839","article-title":"Vascular risk factors, cognitive decline, and dementia","volume":"4","author":"Duron","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"2024051614324389000_7.11.e017416.18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/VHRM.S7343","article-title":"Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review","volume":"6","author":"Ligthart","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"2024051614324389000_7.11.e017416.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70143-1"},{"key":"2024051614324389000_7.11.e017416.20","first-page":"CD003160","article-title":"Statins for the prevention of dementia","volume":"1","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024051614324389000_7.11.e017416.21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000786","article-title":"Reduction of long-term care dependence after an 8-year primary care prevention program for stroke and dementia: the INVADE trial","volume":"1","author":"Bickel","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"2024051614324389000_7.11.e017416.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2012.00928.x"},{"key":"2024051614324389000_7.11.e017416.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009992"},{"key":"2024051614324389000_7.11.e017416.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2024051614324389000_7.11.e017416.25","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.633586"},{"key":"2024051614324389000_7.11.e017416.26","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006309"},{"key":"2024051614324389000_7.11.e017416.27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.004726"},{"key":"2024051614324389000_7.11.e017416.28","doi-asserted-by":"publisher","DOI":"10.1017\/S135561771200077X"},{"key":"2024051614324389000_7.11.e017416.29","doi-asserted-by":"crossref","unstructured":"Intercollegiate Stroke Working Party. National clinical\u00a0guideline for stroke . 4th edn. London: Royal College of Physicians, 2012. https:\/\/www.strokeaudit.org\/Guideline\/Historical-Guideline.aspx (accessed 17 Jul 2017)","DOI":"10.7861\/clinmedicine.17-5-478"},{"key":"2024051614324389000_7.11.e017416.30","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000254549.75763.5f"},{"key":"2024051614324389000_7.11.e017416.31","unstructured":"Beecham J , Knapp M . Measuring Mental Health Needs. In: Thornicroft G , ed, Costing psychiatric interventions. London: Gaskell, 2001:200\u201324."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-017416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T21:32:59Z","timestamp":1715895179000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-017416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,28]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1136\/bmjopen-2017-017416"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-017416","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}